Literature DB >> 20142564

Brain perivascular macrophages and the sympathetic response to inflammation in rats after myocardial infarction.

Yang Yu1, Zhi-Hua Zhang, Shun-Guang Wei, Jordi Serrats, Robert M Weiss, Robert B Felder.   

Abstract

Inflammation is associated with increased sympathetic drive in cardiovascular diseases. Blood-borne proinflammatory cytokines, markers of inflammation, induce cyclooxygenase 2 (COX-2) activity in perivascular macrophages of the blood-brain barrier. COX-2 generates prostaglandin E(2), which may enter the brain and increase sympathetic nerve activity. We examined the contribution of this mechanism to augmented sympathetic drive in rats after myocardial infarction (MI). Approximately 24 hours after acute MI, rats received an intracerebroventricular injection (1 microL/min over 40 minutes) of clodronate liposomes (MI+CLOD) to eliminate brain perivascular macrophages, liposomes alone, or artificial cerebrospinal fluid. A week later, COX-2 immunoreactivity in perivascular macrophages and COX-2 mRNA and protein had increased in hypothalamic paraventricular nucleus of MI rats treated with artificial cerebrospinal fluid or liposomes alone compared with sham-operated rats. In MI+CLOD rats, neither perivascular macrophages nor COX-2 immunoreactivity was seen in the paraventricular nucleus, and COX-2 mRNA and protein levels were similar to those in sham-operated rats. Prostaglandin E(2) in cerebrospinal fluid, paraventricular nucleus neuronal excitation, and plasma norepinephrine were less in MI+CLOD rats than in MI rats treated with artificial cerebrospinal fluid or liposomes alone but more than in sham-operated rats. Intracerebroventricular CLOD had no effect on interleukin 1beta and tumor necrosis factor-alpha mRNA and protein in the paraventricular nucleus or plasma interleukin-1beta and tumor necrosis factor-alpha, which were increased in MI compared with sham-operated rats. In normal rats, pretreatment with intracerebroventricular CLOD reduced (P<0.05) the renal sympathetic, blood pressure, and heart rate responses to intracarotid artery injection of tumor necrosis factor-alpha (0.5 microg/kg); intracerebroventricular liposomes had no effect. The results suggest that proinflammatory cytokines stimulate sympathetic excitation after MI by inducing COX-2 activity and prostaglandin E(2) production in perivascular macrophages of the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142564      PMCID: PMC2890291          DOI: 10.1161/HYPERTENSIONAHA.109.142836

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  39 in total

Review 1.  Sympathetic nervous system, diabetes, and hypertension.

Authors:  P C Perin; S Maule; R Quadri
Journal:  Clin Exp Hypertens       Date:  2001 Jan-Feb       Impact factor: 1.749

2.  Guiding principles for research involving animals and human beings.

Authors: 
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-08       Impact factor: 3.619

3.  Progression of heart failure after myocardial infarction in the rat.

Authors:  J Francis; R M Weiss; S G Wei; A K Johnson; R B Felder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-11       Impact factor: 3.619

4.  Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure.

Authors:  J Francis; R M Weiss; S G Wei; A K Johnson; T G Beltz; K Zimmerman; R B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-11       Impact factor: 4.733

5.  Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins.

Authors:  Zhi-Hua Zhang; Shun-Guang Wei; Joseph Francis; Robert B Felder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-04       Impact factor: 3.619

Review 6.  Cytokine activation of the HPA axis.

Authors:  A J Dunn
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 7.  How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis.

Authors:  S Rivest
Journal:  Psychoneuroendocrinology       Date:  2001-11       Impact factor: 4.905

8.  Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults.

Authors:  Jennifer C Schiltz; Paul E Sawchenko
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

Review 9.  Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms.

Authors:  Y-F Li; K P Patel
Journal:  Acta Physiol Scand       Date:  2003-01

Review 10.  Heart failure and the brain: new perspectives.

Authors:  Robert B Felder; Joseph Francis; Zhi-Hua Zhang; Shun-Guang Wei; Robert M Weiss; Alan Kim Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-02       Impact factor: 3.619

View more
  52 in total

1.  TNF-α receptor 1 knockdown in the subfornical organ ameliorates sympathetic excitation and cardiac hemodynamics in heart failure rats.

Authors:  Yang Yu; Shun-Guang Wei; Robert M Weiss; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-14       Impact factor: 4.733

Review 2.  Mild cold-stress depresses immune responses: Implications for cancer models involving laboratory mice.

Authors:  Michelle N Messmer; Kathleen M Kokolus; Jason W-L Eng; Scott I Abrams; Elizabeth A Repasky
Journal:  Bioessays       Date:  2014-07-25       Impact factor: 4.345

3.  Central SDF-1/CXCL12 expression and its cardiovascular and sympathetic effects: the role of angiotensin II, TNF-α, and MAP kinase signaling.

Authors:  Shun-Guang Wei; Zhi-Hua Zhang; Yang Yu; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-26       Impact factor: 4.733

4.  Early interference with p44/42 mitogen-activated protein kinase signaling in hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension.

Authors:  Yang Yu; Bao-Jian Xue; Zhi-Hua Zhang; Shun-Guang Wei; Terry G Beltz; Fang Guo; Alan Kim Johnson; Robert B Felder
Journal:  Hypertension       Date:  2013-02-25       Impact factor: 10.190

Review 5.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 6.  Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.

Authors:  Bernardo Sousa-Pinto; Manuel J Ferreira-Pinto; Mário Santos; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

Review 7.  Inflammation, Immunity, and Oxidative Stress in Hypertension-Partners in Crime?

Authors:  Ian R Barrows; Ali Ramezani; Dominic S Raj
Journal:  Adv Chronic Kidney Dis       Date:  2019-03       Impact factor: 3.620

Review 8.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

9.  Subfornical organ mediates sympathetic and hemodynamic responses to blood-borne proinflammatory cytokines.

Authors:  Shun-Guang Wei; Zhi-Hua Zhang; Terry G Beltz; Yang Yu; Alan Kim Johnson; Robert B Felder
Journal:  Hypertension       Date:  2013-05-13       Impact factor: 10.190

10.  Brain-mediated dysregulation of the bone marrow activity in angiotensin II-induced hypertension.

Authors:  Joo Yun Jun; Jasenka Zubcevic; Yanfei Qi; Aqeela Afzal; Jessica Marulanda Carvajal; Jeffrey S Thinschmidt; Maria B Grant; J Mocco; Mohan K Raizada
Journal:  Hypertension       Date:  2012-10-08       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.